VHH Antibodies: Emerging Reagents for the Analysis of Environmental Chemicals

Overview

Journal Anal Bioanal Chem

Specialty Chemistry

Date 2016 May 23

PMID 27209591

Citations 58

Authors

Candace S Bever

Jie-Xian Dong

Natalia Vasylieva

Bogdan Barnych

Yongliang Cui

Zhen-Lin Xu

Bruce D Hammock

Shirley J Gee

Affiliations

Soon will be listed here.

Abstract

A VHH antibody (or nanobody) is the antigen binding fragment of heavy chain only antibodies. Discovered nearly 25 years ago, they have been investigated for their use in clinical therapeutics and immunodiagnostics, and more recently for environmental monitoring applications. A new and valuable immunoreagent for the analysis of small molecular weight environmental chemicals, VHH will overcome many pitfalls encountered with conventional reagents. In the work so far, VHH antibodies often perform comparably to conventional antibodies for small molecule analysis, are amenable to numerous genetic engineering techniques, and show ease of adaption to other immunodiagnostic platforms for use in environmental monitoring. Recent reviews cover the structure and production of VHH antibodies as well as their use in clinical settings. However, no report focuses on the use of these VHH antibodies to detect small environmental chemicals (MW < 1500 Da). This review article summarizes the efforts made to produce VHHs to various environmental targets, compares the VHH-based assays with conventional antibody assays, and discusses the advantages and limitations in developing these new antibody reagents particularly to small molecule targets. Graphical Abstract Overview of the production of VHHs to small environmental chemicals and highlights of the utility of these new emerging reagents.

Citing Articles

Molecular imaging of viral pathogenesis and opportunities for the future.

Kelly B, Boudreau J, Beyea S, Brewer K Npj Imaging. 2025; 3(1):3.

PMID: 39872292 PMC: 11761071. DOI: 10.1038/s44303-024-00056-w.

Targeting Brain Drug Delivery with Macromolecules Through Receptor-Mediated Transcytosis.

Li Y, Liu R, Zhao Z Pharmaceutics. 2025; 17(1).

PMID: 39861756 PMC: 11769103. DOI: 10.3390/pharmaceutics17010109.

TEMPRO: nanobody melting temperature estimation model using protein embeddings.

Alvarez J, Dean S Sci Rep. 2024; 14(1):19074.

PMID: 39154093 PMC: 11330463. DOI: 10.1038/s41598-024-70101-6.

Single-Domain Antibody-Gold Nanoparticle Bioconjugates as Immunosensors for the Detection of Hantaviruses.

Bastos-Soares E, Suelen da Silva Morais M, Funes-Huacca M, Sousa R, Brilhante-da-Silva N, Roberto S Mol Diagn Ther. 2024; 28(4):479-494.

PMID: 38796660 DOI: 10.1007/s40291-024-00713-1.

Plant-Derived Anti-Human Epidermal Growth Factor Receptor 2 Antibody Suppresses Trastuzumab-Resistant Breast Cancer with Enhanced Nanoscale Binding.

Park C, Kim K, Kim Y, Zhu R, Hain L, Seferovic H ACS Nano. 2024; 18(25):16126-16140.

PMID: 38764224 PMC: 11210341. DOI: 10.1021/acsnano.4c00360.

References

Muyldermans S . Nanobodies: natural single-domain antibodies. Annu Rev Biochem. 2013; 82:775-97. DOI: 10.1146/annurev-biochem-063011-092449. View

Wang J, Majkova Z, Bever C, Yang J, Gee S, Li J . One-step immunoassay for tetrabromobisphenol a using a camelid single domain antibody-alkaline phosphatase fusion protein. Anal Chem. 2015; 87(9):4741-8. PMC: 4476793. DOI: 10.1021/ac504735p. View

Doyle P, Saeed H, Hermans A, Gleddie S, Hussack G, Arbabi-Ghahroudi M . Intracellular expression of a single domain antibody reduces cytotoxicity of 15-acetyldeoxynivalenol in yeast. J Biol Chem. 2009; 284(50):35029-39. PMC: 2787364. DOI: 10.1074/jbc.M109.045047. View

Turner K, Zabetakis D, Goldman E, Anderson G . Enhanced stabilization of a stable single domain antibody for SEB toxin by random mutagenesis and stringent selection. Protein Eng Des Sel. 2014; 27(3):89-95. DOI: 10.1093/protein/gzu001. View

Anderson G, Goldman E . TNT detection using llama antibodies and a two-step competitive fluid array immunoassay. J Immunol Methods. 2008; 339(1):47-54. DOI: 10.1016/j.jim.2008.08.001. View

Spinelli S, Tegoni M, Frenken L, van Vliet C, Cambillau C . Lateral recognition of a dye hapten by a llama VHH domain. J Mol Biol. 2001; 311(1):123-9. DOI: 10.1006/jmbi.2001.4856. View

Tabares-da Rosa S, Rossotti M, Carleiza C, Carrion F, Pritsch O, Ahn K . Competitive selection from single domain antibody libraries allows isolation of high-affinity antihapten antibodies that are not favored in the llama immune response. Anal Chem. 2011; 83(18):7213-20. PMC: 3193053. DOI: 10.1021/ac201824z. View

Renisio J, Perez J, Czisch M, Guenneugues M, Bornet O, Frenken L . Solution structure and backbone dynamics of an antigen-free heavy chain variable domain (VHH) from Llama. Proteins. 2002; 47(4):546-55. DOI: 10.1002/prot.10096. View

Ladenson R, Crimmins D, Landt Y, Ladenson J . Isolation and characterization of a thermally stable recombinant anti-caffeine heavy-chain antibody fragment. Anal Chem. 2006; 78(13):4501-8. DOI: 10.1021/ac058044j. View

10.

Riazi A, Strong P, Coleman R, Chen W, Hirama T, van Faassen H . Pentavalent single-domain antibodies reduce Campylobacter jejuni motility and colonization in chickens. PLoS One. 2014; 8(12):e83928. PMC: 3877120. DOI: 10.1371/journal.pone.0083928. View

11.

Rahbarizadeh F, Ahmadvand D, Sharifzadeh Z . Nanobody; an old concept and new vehicle for immunotargeting. Immunol Invest. 2011; 40(3):299-338. DOI: 10.3109/08820139.2010.542228. View

12.

Doshi R, Chen B, Vibat C, Huang N, Lee C, Chang G . In vitro nanobody discovery for integral membrane protein targets. Sci Rep. 2014; 4:6760. PMC: 4208029. DOI: 10.1038/srep06760. View

13.

van der Linden R, de Geus B, Stok W, Bos W, Van Wassenaar D, Verrips T . Induction of immune responses and molecular cloning of the heavy chain antibody repertoire of Lama glama. J Immunol Methods. 2000; 240(1-2):185-95. DOI: 10.1016/s0022-1759(00)00188-5. View

14.

Akazawa-Ogawa Y, Uegaki K, Hagihara Y . The role of intra-domain disulfide bonds in heat-induced irreversible denaturation of camelid single domain VHH antibodies. J Biochem. 2015; 159(1):111-21. PMC: 4882646. DOI: 10.1093/jb/mvv082. View

15.

Doyle P, Arbabi-Ghahroudi M, Gaudette N, Furzer G, Savard M, Gleddie S . Cloning, expression, and characterization of a single-domain antibody fragment with affinity for 15-acetyl-deoxynivalenol. Mol Immunol. 2008; 45(14):3703-13. DOI: 10.1016/j.molimm.2008.06.005. View

16.

Alvarez-Rueda N, Behar G, Ferre V, Pugniere M, Roquet F, Gastinel L . Generation of llama single-domain antibodies against methotrexate, a prototypical hapten. Mol Immunol. 2006; 44(7):1680-90. DOI: 10.1016/j.molimm.2006.08.007. View

17.

Saerens D, Conrath K, Govaert J, Muyldermans S . Disulfide bond introduction for general stabilization of immunoglobulin heavy-chain variable domains. J Mol Biol. 2008; 377(2):478-88. DOI: 10.1016/j.jmb.2008.01.022. View

18.

Davenport K, Smith C, Hofstetter H, Horn J, Hofstetter O . Site-directed immobilization of a genetically engineered anti-methotrexate antibody via an enzymatically introduced biotin label significantly increases the binding capacity of immunoaffinity columns. J Chromatogr B Analyt Technol Biomed Life Sci. 2016; 1021:114-121. DOI: 10.1016/j.jchromb.2016.01.021. View

19.

Zhao S, Bukar N, Toulouse J, Pelechacz D, Robitaille R, Pelletier J . Miniature multi-channel SPR instrument for methotrexate monitoring in clinical samples. Biosens Bioelectron. 2014; 64:664-70. DOI: 10.1016/j.bios.2014.09.082. View

20.

Sheedy C, Yau K, Hirama T, MacKenzie C, Hall J . Selection, characterization, and CDR shuffling of naive llama single-domain antibodies selected against auxin and their cross-reactivity with auxinic herbicides from four chemical families. J Agric Food Chem. 2009; 54(10):3668-78. DOI: 10.1021/jf060219i. View